3,235 results on '"Gross, W"'
Search Results
202. Infliximab efficiency in refractory Wegenerʼs granulomatosis
203. BPI–ANCA in transporter associated with antigen presentation (TAP) deficiency: possible role in susceptibility to Gram-negative bacterial infections
204. Escherichia coli as a Complicating Factor of Newcastle Disease Vaccination
205. Case Report: A Synovitis Caused by a Strain of Escherichia coli
206. A critical evaluation of commercial immunoassays for antineutrophil cytoplasmic antibodies directed against proteinase 3 and myeloperoxidase in Wegenerʼs granulomatosis and microscopic polyangiitis
207. Effectiveness of TNF-α blockade with infliximab in refractory Wegenerʼs granulomatosis
208. No difference in the incidences of vasculitides between north and south Germany: first results of the German vasculitis register
209. Elevated monocytic IL-12 and TNF-α production in Wegener’s granulomatosis is normalized by cyclophosphamide and corticosteroid therapy
210. Increased expression of CTLA-4 (CD152) by T and B lymphocytes in Wegenerʼs granulomatosis
211. CD28 negative T cells are enriched in granulomatous lesions of the respiratory tract in Wegenerʼs granulomatosis
212. Amphipathic variable region heavy chain peptides derived from monoclonal human Wegenerʼs anti-PR3 antibodies stimulate lymphocytes from patients with Wegenerʼs granulomatosis and microscopic polyangiitis
213. Improved Differentiation Between Churg-Strauss Syndrome and Wegener's Granulomatosis by an Artificial Neural Network
214. Azathioprine toxicity mimicking a relapse of Wegenerʼs granulomatosis
215. Methotrexate (MTX) failed to control giant cell arteritis (GCA)
216. Immunological and clinical follow up of hepatitis C virus associated cryoglobulinaemic vasculitis
217. Elevated Interleukin-4 and Interleukin-13 Production by T Cell Lines From Patients With Churg-Strauss Syndrome
218. Monitoring of water content and water distribution in ischemic hearts
219. Opsonization of apoptotic neutrophils by anti-neutrophil cytoplasmic antibodies (ANCA) leads to enhanced uptake by macrophages and increased release of tumour necrosis factor-alpha (TNF-α)
220. TAP deficiency syndrome
221. Clinical images: Orbital granuloma and subglottic tracheal stenosis in Wegener’s granulomatosis
222. Granulocyte-macrophage colony-stimulating factor (GM-CSF) but not granulocyte colony-stimulating factor (G-CSF) induces plasma membrane expression of proteinase 3 (PR3) on neutrophils in vitro
223. CRYOGLOBULINEMIC VASCULITIS
224. Transforming Growth Factor β — Multiple Actions in Immune Function and Oncology
225. A Design Framework for Invertible Logic
226. VIS/SWIR IR detectors for space applications at AIM: models and qualification status
227. Costimulatory molecules in Wegener's granulomatosis (WG): lack of expression of CD28 and preferential up-regulation of its ligands B7-1 (CD80) and B7-2 (CD86) on T cells
228. Limitations on the usefulness of procalcitonin as a marker of infection in patients with systemic autoimmune disease: comment on the article by Eberhard et al
229. The complex dielectric spectrum of heart tissue during ischemia
230. Third gen focal plane array IR detection modules at AIM
231. Effect of dienogest-containing oral contraceptives on lipid metabolism
232. The American Health Empire by Barbara, John Ehrenreich (review)
233. Bronchoalveolar lavage cell profile in methotrexate induced pneumonitis
234. Transforming growth factor-beta (TGF-β) expression and interaction with proteinase 3 (PR3) in anti-neutrophil cytoplasmic antibody(ANCA)-associated vasculitis
235. Anti-neutrophil cytoplasmic antibodies (ANCA) directed against bactericidal/permeability increasing protein (BPI): a new seromarker for inflammatory bowel disease and associated disorders
236. Thermophobicity of liquids: Heats of transport in mixtures as pure component properties--The case of arbitrary concentration.
237. Achtes Kapitel
238. Fünftes Kapitel
239. Viertes Kapitel
240. Siebentes Kapitel
241. Drittes Kapitel
242. Zweites Kapitel
243. Erstes Kapitel
244. Erkennung und Differentialdiagnose
245. Ätiologische Probleme
246. Die Klinik
247. Therapie
248. Rheumapathologie
249. Wie Sie das Raynaud-Syndrom erkennen und behandeln
250. Jaccoud-Arthritis bei systemischem Lupus erythematodes
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.